JPWO2021203046A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2021203046A5 JPWO2021203046A5 JP2022560250A JP2022560250A JPWO2021203046A5 JP WO2021203046 A5 JPWO2021203046 A5 JP WO2021203046A5 JP 2022560250 A JP2022560250 A JP 2022560250A JP 2022560250 A JP2022560250 A JP 2022560250A JP WO2021203046 A5 JPWO2021203046 A5 JP WO2021203046A5
- Authority
- JP
- Japan
- Prior art keywords
- cells
- cell
- present
- mitochondria
- modified
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063005167P | 2020-04-03 | 2020-04-03 | |
| US63/005,167 | 2020-04-03 | ||
| PCT/US2021/025643 WO2021203046A1 (en) | 2020-04-03 | 2021-04-02 | Enhancement of adoptive cell transfer |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023521037A JP2023521037A (ja) | 2023-05-23 |
| JPWO2021203046A5 true JPWO2021203046A5 (https=) | 2024-04-15 |
| JP2023521037A5 JP2023521037A5 (https=) | 2024-04-15 |
Family
ID=75919371
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022560250A Pending JP2023521037A (ja) | 2020-04-03 | 2021-04-02 | 養子細胞移植の強化 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US20210309967A1 (https=) |
| EP (1) | EP4127141A1 (https=) |
| JP (1) | JP2023521037A (https=) |
| CN (1) | CN116096861A (https=) |
| AU (1) | AU2021246112A1 (https=) |
| CA (1) | CA3173391A1 (https=) |
| WO (1) | WO2021203046A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12419913B2 (en) | 2019-02-08 | 2025-09-23 | Dna Twopointo, Inc. | Modification of CAR-T cells |
| CN118541160A (zh) * | 2021-10-06 | 2024-08-23 | 赛立维公司 | 通过促进优越的适应性免疫细胞群体增强过继细胞转移 |
| CA3257638A1 (en) | 2022-06-10 | 2023-12-14 | Cellvie Ag | COMPOSITION AND CRYOCONSERVATION PROCESS OF MITOCHONDRIA |
| US20260041767A1 (en) * | 2022-08-02 | 2026-02-12 | National University Corporation Hokkaido University | Methods of improving cellular therapy with organelle complexes |
| WO2024076572A1 (en) * | 2022-10-06 | 2024-04-11 | Mitrix Bio Inc. | Formulations and methods for cellular therapies involving chimeric antigen receptors |
| WO2024097901A1 (en) * | 2022-11-02 | 2024-05-10 | Fate Therapeutics, Inc. | Off-the-shelf therapeutic cells with multiplex genomic engineering for targeting cd79b |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2694549B1 (en) | 2011-04-08 | 2018-08-15 | The United States of America, as represented by The Secretary, Department of Health and Human Services | Anti-epidermal growth factor receptor variant iii chimeric antigen receptors and use of same for the treatment of cancer |
| US11491480B2 (en) | 2014-06-13 | 2022-11-08 | Children's Medical Center Corporation | Products and methods to isolate mitochondria |
| WO2016008937A1 (en) * | 2014-07-16 | 2016-01-21 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods for the intercellular transfer of isolated mitochondria in recipient cells |
| AU2015343013B2 (en) * | 2014-11-05 | 2020-07-16 | Board Of Regents, The University Of Texas System | Gene modified immune effector cells and engineered cells for expansion of immune effector cells |
| SI4272834T1 (sl) * | 2016-01-15 | 2026-03-31 | Beth Israel Deaconess Medical Center, Inc. | Terapevtska uporaba mitohondrijev in kombiniranih mitohondrijskih sredstev |
| WO2018088875A2 (ko) * | 2016-11-14 | 2018-05-17 | 주식회사 파이안에스테틱스 | 외래 미토콘드리아를 포함하는 자연살해세포 및 이를 포함하는 약학적 조성물 |
| JP7524157B2 (ja) * | 2018-07-22 | 2024-07-29 | ミノヴィア セラピューティクス リミテッド | 脳疾患のミトコンドリア増強療法 |
| KR20210042125A (ko) * | 2018-08-07 | 2021-04-16 | 퍼듀 리서치 파운데이션 | Car t 세포의 회생 |
| EP3837359A4 (en) * | 2018-08-14 | 2022-05-11 | Imel Biotherapeutics, Inc. | METHODS AND COMPOSITIONS FOR THE TREATMENT OF MITOCHONDRIAL DISEASES OR DISORDERS AND HETEROPLASMIA |
| CA3172402A1 (en) * | 2020-03-31 | 2021-10-07 | Minovia Therapeutics Ltd. | Mitochondria-enriched genetically engineered cells and uses thereof |
-
2021
- 2021-04-02 CN CN202180032504.XA patent/CN116096861A/zh active Pending
- 2021-04-02 JP JP2022560250A patent/JP2023521037A/ja active Pending
- 2021-04-02 WO PCT/US2021/025643 patent/WO2021203046A1/en not_active Ceased
- 2021-04-02 CA CA3173391A patent/CA3173391A1/en active Pending
- 2021-04-02 US US17/221,625 patent/US20210309967A1/en not_active Abandoned
- 2021-04-02 EP EP21725850.8A patent/EP4127141A1/en active Pending
- 2021-04-02 AU AU2021246112A patent/AU2021246112A1/en active Pending
-
2023
- 2023-07-21 US US18/356,949 patent/US20240052310A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7450892B2 (ja) | Ｎｋ細胞のための人工ｈｌａ陽性フィーダー細胞株及びその使用 | |
| US20200038443A1 (en) | Multi-function and multi-targeting car system and methods for use thereof | |
| JP2025000906A (ja) | 固形腫瘍を標的とする二重特異性ｃａｒ ｔ細胞 | |
| CN118420783A (zh) | 嵌合蛋白、表达嵌合蛋白的免疫效应细胞及其应用 | |
| WO2019052562A1 (zh) | Il-4r的融合蛋白及其应用 | |
| EP3789486A1 (en) | Immune effector cell and use thereof | |
| WO2022037562A1 (en) | Engineered immunoresponsive cells and uses thereof | |
| WO2021057906A1 (zh) | 表达il-15的免疫效应细胞 | |
| WO2020143631A1 (zh) | 细胞免疫治疗的组合 | |
| WO2021052496A1 (zh) | 细胞因子调控表达的免疫效应细胞 | |
| JP2021513860A (ja) | ユニバーサル抗原提示細胞およびその使用 | |
| EP4138864A1 (en) | Polyspecific binding molecules and their use in cell therapy | |
| WO2022057941A1 (zh) | 表达il-7r结合蛋白的免疫效应细胞 | |
| JP2025520124A (ja) | キメラアダプターポリペプチドを含む組成物及び方法 | |
| JP2024515815A (ja) | 組換え抗原提示細胞 | |
| JPWO2021203046A5 (https=) | ||
| WO2022092277A1 (ja) | Ｃｘｃｌ１２受容体発現キメラ抗原受容体（ｃａｒ）－ｔ細胞 | |
| WO2022095903A1 (zh) | 靶向pd-1h(vista)的抗肿瘤免疫治疗方法 | |
| EP3991746A1 (en) | Transfection method | |
| WO2023284875A1 (zh) | 嵌合抗原受体 | |
| CN118477171A (zh) | 脂质纳米颗粒 (lnp) 及其在细胞治疗中的用途 | |
| US20240075085A1 (en) | Cancer therapy involving car-engineered t-cells and parvovirus h-1 | |
| WO2025103439A1 (zh) | 一种嵌合抗原受体及其应用 | |
| WO2025130895A1 (zh) | 一种免疫细胞的制备方法及其用途 | |
| WO2024124244A1 (en) | Cd38 as integration site for enhanced function of gene-modified immune cells |